Literature DB >> 10865209

The immediate early gene product hCYR61 localizes to the secretory pathway in human osteoblasts.

A Lechner1, N Schütze, H Siggelkow, J Seufert, F Jakob.   

Abstract

The human cysteine-rich protein 61 (hCYR61) belongs to the growing CCN (CYR61/CTGF/NOV) family of immediate early genes, which modulate cell growth and differentiation. hCYR61 is regulated by 1alpha, 25-dihydroxyvitamin D(3) (1,25-(OH)(2)D(3)) and growth factors in fetal human osteoblasts (hFOB cells). The murine homologue CYR61 was characterized as an extracellular matrix-associated protein that modulates basic fibroblast growth factor signaling, angiogenesis, and binds to integrin alpha(v)beta(3). Here we report the intracellular localization of the human CYR61 gene product by overexpressing fusion proteins with green fluorescent protein (GFP) in primary osteoblasts and the hFOB cell line. Full-length hCYR61-GFP localizes to the Golgi apparatus and cytoplasmatic granules, indicating targeting to the secretory pathway. Secretion of hCYR61 from osteoblasts is verified by Western blot detection from cellular supernatants. A truncated hCYR61-GFP fusion protein containing only the 34 N-terminal amino acids of hCYR61 also localizes to the Golgi apparatus mainly in the perinuclear region, which suggests that the N-terminus of hCYR61 is sufficient to target the protein to the secretory pathway. In summary, our results present the first evidence that human CYR61 localizes to the secretory pathway in primary osteoblasts and hFOB cells, and that it is secreted from these cells. The N-terminal 34 amino acids of hCYR61 provide a sufficient Golgi targeting sequence. Together with the immediate early regulation of hCYR61 mRNA by 1,25-(OH)(2)D(3), this suggests that hCYR61 might function as an extracellular signaling molecule in human bone.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10865209     DOI: 10.1016/s8756-3282(00)00294-5

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  7 in total

1.  CCN proteins, microenvironment, communication and signaling: why did we need a new journal?

Authors:  Annick Perbal; Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2007-05-25       Impact factor: 5.782

2.  Caveolin-1 regulates the secretion and cytoprotection of Cyr61 in hyperoxic cell death.

Authors:  Yang Jin; Hong Pyo Kim; Jiaofei Cao; Meng Zhang; Emeka Ifedigbo; Augustine M K Choi
Journal:  FASEB J       Date:  2008-09-18       Impact factor: 5.191

3.  CYR61 regulates BMP-2-dependent osteoblast differentiation through the {alpha}v{beta}3 integrin/integrin-linked kinase/ERK pathway.

Authors:  Jen-Liang Su; Jean Chiou; Chih-Hsin Tang; Ming Zhao; Chun-Hao Tsai; Pai-Sheng Chen; Yi-Wen Chang; Ming-Hsien Chien; Chu-Ying Peng; Michael Hsiao; Ming-Liang Kuo; Men-Luh Yen
Journal:  J Biol Chem       Date:  2010-07-30       Impact factor: 5.157

4.  Osteopoietic engraftment after bone marrow transplantation: effect of inbred strain of mice.

Authors:  Satoru Otsuru; Ted J Hofmann; Valeria Rasini; Elena Veronesi; Massimo Dominici; Edwin M Horwitz
Journal:  Exp Hematol       Date:  2010-05-04       Impact factor: 3.084

5.  5' flanking sequence of the human immediate early responsive gene ccn1 (cyr61) and mapping of polymorphic CA repeat sequence motifs in the human ccn1 (cyr61) locus.

Authors:  N Schütze; N Rücker; J Müller; J Adamski; F Jakob
Journal:  Mol Pathol       Date:  2001-06

6.  Differential expression of CCN-family members in primary human bone marrow-derived mesenchymal stem cells during osteogenic, chondrogenic and adipogenic differentiation.

Authors:  Norbert Schutze; Ulrich Noth; Jutta Schneidereit; Christian Hendrich; Franz Jakob
Journal:  Cell Commun Signal       Date:  2005-03-17       Impact factor: 5.712

7.  CYR61-An angiogenic biomarker to early predict the impaired healing in diaphyseal tibial fractures.

Authors:  Sabir Ali; Ajai Singh; Abbas Ali Mahdi; Rajeshwar Nath Srivastava
Journal:  J Orthop Translat       Date:  2017-02-23       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.